# Changes of GH-IGFs and its relationship with growth retardation in children with bronchial asthma

## TL;DR

This study investigates how growth hormone and insulin-like growth factors relate to growth issues in children with asthma.

## Contribution

The study identifies specific GH-IGFs parameters as potential diagnostic indicators for growth retardation in children with bronchial asthma.

## Key findings

- GH, IGF-1, and IGFBP3 levels decrease with increasing asthma severity.
- Lower GH and IGF-1 levels are risk factors for growth retardation in asthmatic children.
- Combined detection of GH-IGFs shows higher diagnostic accuracy for growth retardation.

## Abstract

•GH-IGFs-related parameters.•GH-IGFs-related parameters in patients with different severity of bronchial asthma.•Correlation analysis of GH-IGFs-related parameters and severity of bronchial asthma.•GH-IGFs-related parameters in patients with or without growth retardation.•Diagnostic value of GH-IGFs-related indicators in growth retardation.•Logistic regression analysis of GH-IGFs-related indicators and growth retardation.

GH-IGFs-related parameters.

GH-IGFs-related parameters in patients with different severity of bronchial asthma.

Correlation analysis of GH-IGFs-related parameters and severity of bronchial asthma.

GH-IGFs-related parameters in patients with or without growth retardation.

Diagnostic value of GH-IGFs-related indicators in growth retardation.

Logistic regression analysis of GH-IGFs-related indicators and growth retardation.

To explore the relationship between Growth Hormone Insulin-like Growth Factors (GH-IGFs) and growth retardation in children with bronchial asthma.

112 children with bronchial asthma and 50 healthy children were studied. Serum GH, IGF-1, and Insulin-like Growth Factor Binding Protein 3 (IGFBP3) were assessed by ELISA. GH-IGFs-related parameters were compared, and the correlation between the parameters and bronchial asthma severity was analyzed. The bronchial asthma group was divided into the growth retardation group and non-growth retardation group to analyze the diagnostic value of GH-IGFs in growth retardation and the relationship between GH-IGFs and growth retardation.

GH, IGF-1, and IGFBP3 in the bronchial asthma group were lower. GH, IGF-1, and IGFBP3 levels were decreased with the severity of bronchial asthma. GH, IGF-1, and IGFBP3 in the growth retardation group were lower than those in the non-growth retardation group. The AUC of GH-IGFs combined detection was higher than that of GH and IGFBP3 alone detection. GH < 9.27 μg/L and IGF-1 < 179.53 mmoL/L were risk factors for growth retardation in patients with bronchial asthma.

GH-IGFs-related parameters have diagnostic value for growth retardation in children, and decreased levels of GH and IGF-1 are risk factors for growth retardation in children.